Amal El-Mabhouh

A 99mTc-labeled gemcitabine bisphosphonate drug conjugate as a probe to assess the potential for targeted chemotherapy of metastatic bone cancer

Amal El-Mabhouh, Christo A. Angelov, Ron G Cavell et al. · Nuclear Medicine and Biology · 2006 · 36 citations

Medicine, Oncology, Pharmacology +16

188Re-labeled bisphosphonates as potential bifunctional agents for therapy in patients with bone metastases

Amal El-Mabhouh, John R. Mercer · Applied Radiation and Isotopes · 2004 · 29 citations

Medicine, Oncology, Pharmacology +16

Preclinical Investigations of Drug and Radionuclide Conjugates of Bisphosphonates for the Treatment of Metastatic Bone Cancer

Amal El-Mabhouh, Christo M. Angelov, Alexander McEwan et al. · Cancer Biotherapy and Radiopharmaceuticals · 2004 · 29 citations

Medicine, Oncology, Pharmacology +17

188Re-labelled gemcitabine/bisphosphonate (Gem/BP): a multi-functional, bone-specific agent as a potential treatment for bone metastases

Amal El-Mabhouh, John R. Mercer · European Journal of Nuclear Medicine and Molecular Imaging · 2008 · 26 citations

Medicine, Nuclear Medicine, Oncology +16

A Conjugate of Gemcitabine With Bisphosphonate (Gem/BP) Shows Potential as a Targeted Bone-Specific Therapeutic Agent in an Animal Model of Human Breast Cancer Bone Metastases

Amal El-Mabhouh, P. N. Nation, Jonathan Abele et al. · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · 2011 · 23 citations · Full text

Medicine, Oncology, Pharmacology +17